Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. -Market presence across multiple geographies - Strong/Active/Niche/Trivial.
New York, June 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vascular Closure Devices Industry" - https://www.reportlinker.com/p05896474/?utm_source=GNW -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass Research Platform -Complimentary updates for one year Global Vascular Closure Devices Market to Reach $1 Billion by 2026 A vascular closure device is a medical device designed to provide rapid hemostasis and reduce vascular complications after percutaneous femoral access and. Vascular closure devices also improve patient comfort, reduce discomfort associated with prolonged bed rest, facilitate early patient mobilization, and decrease hospital length of stay. These devices have emerged as an effective alternative to traditional mechanical compression for femoral artery closure. Suture-based and metal clip-based vascular closure devices reduce time to hemostasis when compared with manual or mechanical compression. Vascular closure devices are being widely used in patients undergoing cardiac catheterization through femoral arterial access. Cardiovascular procedures that require catheterization include interventional procedures such as angioplasty, coronary thrombectomy and placement of a stent, and diagnostic procedures that help diagnose diseased blood vessels. Most vascular closure devices leave foreign bodies within the artery and/or surrounding soft tissues. Recent methods to close the access site involve the use of novel materials such as sealants comprised of polyethylene glycol that dissolve over a short period of time. Amid the COVID-19 crisis, the global market for Vascular Closure Devices estimated at US$731.5 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2026, growing at a CAGR of 6.8% over the analysis period. Passive Approximators, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$783.3 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Active Approximators segment is readjusted to a revised 6% CAGR for the next 7-year period. The U.S. Market is Estimated at $323 Million in 2021, While China is Forecast to Reach $110.5 Million by 2026 The Vascular Closure Devices market in the U.S. is estimated at US$323 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$110.5 Million by the year 2026 trailing a CAGR of 8.2% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR. The market is expected to witness steady growth in the long term due to the increasing number of femoral artery cardiac catheterization, the benefits of reduced hemostasis time, and enhanced patient comfort. Vascular closure devices seal femoral artery punctures in patients who have undergone interventional procedures or diagnostic angiography procedures. In countries across the world, approvals for new vascular closure devices are increasing. This combined with the other factors of rising government support and initiatives and growing demand among patients for more advanced treatment options for cardiovascular diseases is expected to result in steady growth for the market over the long term. Market players aggressively invest in research for new products which is also a major market growth driver. Another important growth driving factor is the higher efficiency rate of the new devices that have entered the market in the recent years. In the current era where healthcare is cutting down on costs, there is a shift in focus for technologies from manual compression for hemostasis to fasten vascular closure. Although these devices increase the procedural costs, in the long run, it is cost-effective. Faster hemostasis reduces bleeding complications, saves nursing time after the procedure, increases patient throughput, quickens patient ambulation, and increases overall patient satisfaction. Further, it supports hospitals following percutaneous coronary intervention (PCI) programs. The devices are classified into three sections - vascular closure devices that instantly closes the vessel using mechanical process; compression devices that fasten onto the patient to enable pressure on the arteriotomy site; and hemostatic pads comprising materials to fasten the clotting force to lower time to hemostasis. Typically, manual compression is used in combination with hemostatic pads. External Hemostatic Devices Segment to Reach $137.4 Million by 2026 This category comprises pads or patches and aid in the promotion of coagulation through concentrating clotting devices and factors, which exert pressure manually on the arteriotomy. With increased employment of transradial access in several centers, the use of external hemostatic devices are increasing across various settings. Due to several advantages associated with transradial access in comparison to transfemoral access. In terms of cost also, radial hemostatic devices are affordable in comparison to several VCDs, which are used after the transfemoral access. In the global External Hemostatic Devices segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.9 Million in the year 2020 will reach a projected size of US$125.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.3 Million by the year 2026, while Latin America will expand at a 4.9% CAGR through the analysis period. Select Competitors (Total 36 Featured) -
Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Vascular Closure Devices - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) Vascular Closure Devices - A Prelude Benefits Active Approximators Passive Approximators External Hemostatic Devices Vascular Closure Devices to Witness Steady Growth Post COVID-19 Interventional Cardiology to Dominate the Market Passive Approximators Lead the Market Femoral Access Type Leads the Market United States Holds a Dominant Share, Asia-Pacific to Witness Rapid Growth Competition Growth Restraints 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS Medical Device Companies Focus on Developing Advanced Biomechanical VCDs Increasing Demand for Large-bore Vascular Closure Devices Select Large Bore Closure Devices Cardiovascular Diseases: A Significant Contributor to Market Growth Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others Global Annual Medical Cost of CVD in US$ Billion (2010-2030) Rising Preference for Minimally Invasive Procedures Boosts Market Prospects Aging Population Drives Demand for Vascular Closure Devices Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030 Life Expectancy for Select Countries in Number of Years: 2019 Increasing Healthcare Expenditure to Foster Growth World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018 Recent Approvals and Launches Essential Medical Inc Receives FDA Clearance for its Large-Bore Vascular Closure Device Vascade MVP Vascular Closure System Obtains Approval from FDA Large Bore PerQseal Closure Device Introduced in Europe Cordis Introduces Mynx Control Vascular Closure Device FDA Approves Teleflex’s Vascular Closure Device Vasorum Set to Commercialize a New Vascular Closure Device across the US 4. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 Table 4: World Recent Past, Current & Future Analysis for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Passive Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 7: World Recent Past, Current & Future Analysis for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Active Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 10: World Recent Past, Current & Future Analysis for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for External Hemostatic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 13: World Recent Past, Current & Future Analysis for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Interventional Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 16: World Recent Past, Current & Future Analysis for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Interventional Radiology/Vascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 19: World Recent Past, Current & Future Analysis for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Femoral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 22: World Recent Past, Current & Future Analysis for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Radial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 III. MARKET ANALYSIS UNITED STATES Vascular Closure Devices Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in the United States for 2022 (E) Table 25: USA Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 26: USA Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: USA 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 28: USA Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 29: USA Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: USA 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 31: USA Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 32: USA Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: USA 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 CANADA Table 34: Canada Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: Canada Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: Canada 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 37: Canada Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: Canada Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: Canada 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 40: Canada Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: Canada Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: Canada 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 JAPAN Vascular Closure Devices Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in Japan for 2022 (E) Graying Population Spurs Growth of Vascular Closure Devices Table 24: Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups Table 43: Japan Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Japan Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: Japan 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 46: Japan Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Japan Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Japan 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 49: Japan Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Japan Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Japan 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 CHINA Vascular Closure Devices Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in China for 2022 (E) Table 52: China Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: China Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: China 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 55: China Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: China Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: China 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 58: China Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: China Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: China 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 EUROPE Vascular Closure Devices Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in Europe for 2022 (E) Ageing Demography - An Opportunity Indicator European Population by Age Group (2016, 2030 & 2050): Percentage Share Breakdown by Age Group for 0-14, 15-64, and 65 & Above Table 61: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 62: Europe Historic Review for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Europe 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 Table 64: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Europe 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 67: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Europe 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 70: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Europe 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 FRANCE Vascular Closure Devices Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in France for 2022 (E) Table 73: France Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: France Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: France 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 76: France Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: France Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: France 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 79: France Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: France Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: France 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 GERMANY Vascular Closure Devices Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in Germany for 2022 (E) Table 82: Germany Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: Germany Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Germany 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 85: Germany Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Germany Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Germany 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 88: Germany Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Germany Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Germany 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 ITALY Table 91: Italy Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Italy Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Italy 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 94: Italy Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Italy Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Italy 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 97: Italy Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: Italy Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: Italy 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 UNITED KINGDOM Vascular Closure Devices Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in the United Kingdom for 2022 (E) Table 100: UK Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: UK Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: UK 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 103: UK Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: UK Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: UK 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 106: UK Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: UK Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: UK 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 SPAIN Table 109: Spain Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: Spain Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: Spain 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2021 & 2027 Table 112: Spain Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: Spain Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: Spain 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2021 & 2027 Table 115: Spain Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: Spain Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: Spain 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2021 & 2027 RUSSIA Table 118: Russia Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Please contact our Customer Support Center to get the complete Table of Contents Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
U.S. stocks closed with a modest bounce on Friday but still suffered the biggest weekly percentage decline in months as investors wrestled with the growing likelihood of a recession as global central banks tried to stamp out inflation. Stubbornly high inflation has unnerved investors this year as the U.S. Federal Reserve and most major central banks have begun to pivot from easy monetary policies to tightening measures which will slow the economy, possibly causing a recession, and potentially dent corporate earnings. The benchmark S&P 500 index suffered its biggest weekly percentage drop since January.
The cryptocurrency industry was built on swagger, enthusiasm and optimism. All three are in short supply these days, as losses and layoffs mount.
Cryptocurrencies remain under pressure as Bitcoin approaches multi-year lows amid relentless, week-long selling in the digital asset space.
Stocks ended mostly higher but still wound up with their biggest weekly losses since markets went into freefall at the onset of coronavirus lockdowns.
Buffett swapped out Wells Fargo and Goldman Sachs for a beaten-down bank.
The Bitcoin carnage continues, as the cryptocurrency breaks $20,000 to trade at its lowest level since 2020.
The bear market sell-off worsened on fears that the Fed will trigger a recession to control inflation. Yields hit highs. Oil prices tumbled.
Alicia Munnell, head of the Boston College Center for Retirement Research, offers three ways to shore up the system: raise taxes to bolster Social Security, make workplace retirement plans available to all workers, and encourage many Americans to work longer.
Comments from the Fed chair were a reminder that the central bank is adamant about keeping a lid on inflation—and economic demand.
(Bloomberg) -- Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcast.Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid SchemeMonkeypox Testing Shows the US Learned Little From the Covid-19 PandemicFederal Reserve Governor Christopher Waller sa
Plus, a newcomer rolled out an artificial intelligence-based ETF.
The Hong Kong Monetary Authority (HKMA) announced a joint research project with the Bank of Israel (BOI) and the Bank for International Settlements Innovation Hub (BISIH) Hong Kong Centre to study cybersecurity issues in retail central bank digital currencies (CBDCs). See related article: Hong Kong now exploring retail CBDC in upcoming Project Aurum Fast facts […]
If it finishes below the 10-week line less than nine straight weeks, then rebounds vigorously, the stock is showing resilience. Consider Boot Barn, which made a spectacular run since the coronavirus market crash ended in March of 2020. Boot Barn fell 13.5% that week and clipped its 10-week line, which rose to 115.09.
BMO Capital initiated coverage of Intellia Therapeutics Inc (NASDAQ: NTLA) with a Market Perform rating and a $54 target price. The analyst says Intellia's gene-editing platform could potentially deliver transformative therapies. But challenges around the lack of clarity around an IND approval in the U.S., ongoing CRISPR/Cas9 IP litigations with Editas Medicine Inc (NASDAQ: EDIT), and high patient compliance remains. Related: Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag
The Fed on Friday signaled it will not let anything stand in the way of its battle to bring down searing inflation
Honda, like bigger rival Toyota Motor, has been slower to shift to electric vehicles (EV) than global automakers and is under pressure from investors to make cars that are carbon-free and equipped with newer technology such as self-driving features. The car maker, which only offers one EV, Honda e, has said it plans to roll out 30 EV models and make some 2 million EVs annually by 2030. To the JV, first announced in March and named Sony Honda Mobility, Honda will bring its expertise in building and selling cars and Sony will add its software and technology chops, the companies said in a statement on Thursday.
(Bloomberg) -- Crypto broker Voyager Digital Ltd said it secured loans from Alameda Research, the trading outfit from FTX founder Sam Bankman-Fried, to shore up protection for customer assets while activity in the digital asset market remains highly volatile.Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for A
The first economist on Wall Street to predict a U.S. recession in 2023 is moving up his timeline for an economic contraction.
Nervous investors flock to long-term Treasury bonds on Friday, sending yields down for a third day this week.
(Bloomberg) -- Britain’s policy makers are hardening their attitude toward inflation, preparing to deliver a tough dose of medicine at a time when a cost-of-living crisis is weighing down growth and consumers.Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid SchemeMonkeypox Testing Sh